Epineuron Logo

About us

Despite all modern advancements in reconstructive surgery for peripheral nerve repair, recovery remains painful, frustrating, and unsatisfactory due to the absence of treatment options. Without medications or devices to support recovery after surgery for transected or severely compressed nerves, patients are often left with long term numbness, pain and loss of movement, impacting their quality of life and earning potential. Epineuron is a clinical-stage medical device company developing the first therapeutic treatment for injured peripheral nerves. The company’s lead product delivers a unique bioelectronic therapy that accelerates nerve regeneration, resulting in better and earlier overall functional recovery (movement and sensation) for patients. It’s a single-use wearable used after nerve repair surgery and has been designated a Breakthrough Device by the FDA.

Program engagement

Leadership

Sergio Aguirre

Founder and CEO

Mike Willand

Founder and CTO

Status

Intellectual Property

Sector

Subsector

Synapse Life Science Pitch Competition applications open. Apply by November 10, 2024

Applications for the 2025 Synapse Competition are open!

The Synapse Life Science Competition combines the ideas and research of life science innovators with the intellect and strategy of students. Finalists receive training, mentorship, a $2,000 grant and a chance to pitch and compete for BIG cash prizes!

Applications close on November 10, 2024.